U.S. subsidiary of Eastern Capital-backed Highland Therapeutics taps new president
Ironshore Pharmaceuticals (America) Inc., the U.S. subsidiary of pharmaceutical company Highland Therapeutics Inc., appointed Craig S. Lewis as president. Lewis, formerly SVP at Assurex Health, has been a member of IPA's board of directors since August 2015, and will retain that role. Highland is backed by Eastern Capital Limited, which led a $50 million financing in June 2015.



